ECPR for Refractory Out-Of-Hospital Cardiac Arrest

NCT03065647 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2021-06-03

Study results available
· View outcomes & findings →

Summary

In the U.S. alone, over 300,000 people per year have sudden out-of-hospital cardiac arrest (OHCA), and less than 1 out of 10 survive. The current standard practice for treating OHCA is to perform cardiopulmonary resuscitation (CPR) and Advanced Cardiovascular Life Support (ACLS) at the scene until either the heart is restarted or resuscitation efforts are considered hopeless and discontinued. An alternative strategy for those with refractory OHCA is expedited transport with ongoing mechanical CPR to an Emergency Department capable of performing extracorporeal cardiopulmonary resuscitation (ECPR). The purpose of study is to test if this strategy is feasible and beneficial.

Conditions

  • Cardiac Arrest
  • Heart Arrest
  • Sudden Cardiac Arrest
  • Cardiopulmonary Arrest
  • Death, Sudden, Cardiac
  • Cardiopulmonary Resuscitation
  • CPR
  • Extracorporeal Cardiopulmonary Resuscitation
  • Extracorporeal Membrane Oxygenation

Interventions

DEVICE

Expedited Transport With Mechanical CPR

Patients with OHCA refractory to initial BLS and ACLS will be transported by EMS with ongoing mechanical CPR and ACLS to an emergency department capable of initiating ECPR.

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH
  • Food and Drug Administration (FDA)

    collaborator FED
  • Physio-Control

    collaborator INDUSTRY
  • University of Michigan

    lead OTHER

Principal Investigators

  • Robert W Neumar, MD, PhD · University of Michigan

  • Robert H Bartlett, MD · University of Michigan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-05-01
Primary Completion
2020-03-05
Completion
2020-03-05
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03065647 on ClinicalTrials.gov